Maneskin, bagno di folla a Roma: la band ricevuta dalla sindaca Raggi lapresse.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lapresse.it Daily Mail and Mail on Sunday newspapers.
Måneskin treedt deze zomer ook op in Ronquières nieuwsblad.be - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nieuwsblad.be Daily Mail and Mail on Sunday newspapers.
617 Serious Adverse Events After Vaccination Reported In India Until March 29 09/04/2021
A medical worker holds a vial of AstraZeneca’s COVID-19 vaccine at a vaccination centre in Ronquieres, Belgium, April 6, 2021. Photo: Reuters/Yves Herman/File Photo
Bengaluru: As of March 29, 2021, at least 617 serious adverse events following immunisation (AEFI) had been reported from around the country, according to a presentation made before the National AEFI Committee two days later. Of these 617, at least 180 people (29.2%) died, and of these, complete documents were available only for 35 people (19.4%).
According to vaccine scientist Dr Gagandeep Kang, there are five types of AEFIs: vaccine product related reaction, vaccine quality defect related reaction, immunisation error related reaction, immunisation anxiety related reaction and coincidental event. The National AEFI Committee is tasked with determining the type of each AEFI in the country and, where applicable, arrangi
Un estudi posa xifres als riscos i beneficis de la vacuna d AstraZeneca ccma.cat - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ccma.cat Daily Mail and Mail on Sunday newspapers.
PM orders full review of EMA s findings before resuming use of AstraZeneca vaccine
Posted : 2021-04-08 11:18
Updated : 2021-04-08 13:27
A vial of AstraZeneca COVID-19 vaccine is seen at a vaccination center amid the coronavirus disease outbreak, in Ronquieres, Belgium, April 6. Reuters
Prime Minister Chung Sye-kyun on Thursday ordered health authorities to thoroughly and swiftly review the latest findings by the European Medicines Agency (EMA) on the safety of AstraZeneca s vaccine.
The Korea Disease Control and Prevention Agency should swiftly reach a scientific conclusion on the findings and share the results with the public in a transparent manner, he said.
While rare blood clots have been reported among people administered with the vaccine, the EMA said the benefits (of administering the vaccine) outweigh the risks, he added.